Terms: = Leukemia AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280
32 results:
1. SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
Wu DL; Wang Y; Zhang TJ; Chu MQ; Xu ZJ; Yuan Q; Ma JC; Lin J; Qian J; Zhou JD
Eur J Med Res; 2022 Nov; 27(1):259. PubMed ID: 36411451
[TBL] [Abstract] [Full Text] [Related]
2. MiR-24-3p attenuates IL-1β-induced chondrocyte injury associated with osteoarthritis by targeting BCL2L12.
Xu J; Qian X; Ding R
J Orthop Surg Res; 2021 Jun; 16(1):371. PubMed ID: 34116684
[TBL] [Abstract] [Full Text] [Related]
3. Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe.
Kabra M; Margotto L; Manuguid F
Future Oncol; 2021 Jul; 17(21):2769-2784. PubMed ID: 33881356
[TBL] [Abstract] [Full Text] [Related]
4. Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death.
Tregnago C; Da Ros A; Porcù E; Benetton M; Simonato M; Simula L; Borella G; Polato K; Minuzzo S; Borile G; Cogo P; Campello S; Massi A; Romagnoli R; Buldini B; Locatelli F; Pigazzi M
Blood Adv; 2020 Sep; 4(18):4417-4429. PubMed ID: 32931582
[TBL] [Abstract] [Full Text] [Related]
5. The incidence of cytokine release syndrome and neurotoxicity of CD19 chimeric antigen receptor-T cell therapy in the patient with acute lymphoblastic leukemia and lymphoma.
Cao JX; Wang H; Gao WJ; You J; Wu LH; Wang ZX
Cytotherapy; 2020 Apr; 22(4):214-226. PubMed ID: 32305113
[TBL] [Abstract] [Full Text] [Related]
6. Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study.
Montesinos P; Roboz GJ; Bulabois CE; Subklewe M; Platzbecker U; Ofran Y; Papayannidis C; Wierzbowska A; Shin HJ; Doronin V; Deneberg S; Yeh SP; Ozcan MA; Knapper S; Cortes J; Pollyea DA; Ossenkoppele G; Giralt S; Döhner H; Heuser M; Xiu L; Singh I; Huang F; Larsen JS; Wei AH
Leukemia; 2021 Jan; 35(1):62-74. PubMed ID: 32203138
[TBL] [Abstract] [Full Text] [Related]
7. Genetic Disorders in Prenatal Onset Syndromic Short Stature Identified by Exome Sequencing.
Homma TK; Freire BL; Honjo Kawahira RS; Dauber A; Funari MFA; Lerario AM; Nishi MY; Albuquerque EV; Vasques GA; Collett-Solberg PF; Miura Sugayama SM; Bertola DR; Kim CA; Arnhold IJP; Malaquias AC; Jorge AAL
J Pediatr; 2019 Dec; 215():192-198. PubMed ID: 31630891
[TBL] [Abstract] [Full Text] [Related]
8. Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.
Munakata W; Ando K; Hatake K; Fukuhara N; Kinoshita T; Fukuhara S; Shirasugi Y; Yokoyama M; Ichikawa S; Ohmachi K; Gion N; Aoi A; Tobinai K
Cancer Sci; 2019 May; 110(5):1686-1694. PubMed ID: 30815927
[TBL] [Abstract] [Full Text] [Related]
9. A Pilot Study of Aberrant CpG Island Hypermethylation of
Sun J; Zhang J; Wang Y; Li Y; Zhang R
Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
[No Abstract] [Full Text] [Related]
10. Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis.
Ji Q; Xu X; Kang L; Xu Y; Xiao J; Goodman SB; Zhu X; Li W; Liu J; Gao X; Yan Z; Zheng Y; Wang Z; Maloney WJ; Ye Q; Wang Y
Nat Commun; 2019 Jan; 10(1):313. PubMed ID: 30659184
[TBL] [Abstract] [Full Text] [Related]
11. Squamoid eccrine ductal carcinoma.
Jacob J; Kugelman L
Cutis; 2018 May; 101(5):378;380;385. PubMed ID: 29894529
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.
Jaime-Pérez JC; Borrego-López MF; Jiménez-Castillo RA; Méndez-Ramírez N; Salazar-Riojas R; Fernández LT; Gómez-Almaguer D
Int J Lab Hematol; 2018 Apr; 40(2):169-174. PubMed ID: 29115725
[TBL] [Abstract] [Full Text] [Related]
13. Incidence of type 2 diabetes mellitus and hyperlipidemia in patients prescribed dasatinib or nilotinib as first- or second-line therapy for chronic myelogenous leukemia in the US.
Franklin M; Burns L; Perez S; Yerragolam D; Makenbaeva D
Curr Med Res Opin; 2018 Feb; 34(2):353-360. PubMed ID: 29095654
[TBL] [Abstract] [Full Text] [Related]
14. Cancer Risk After Pediatric Solid Organ Transplantation.
Yanik EL; Smith JM; Shiels MS; Clarke CA; Lynch CF; Kahn AR; Koch L; Pawlish KS; Engels EA
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557749
[TBL] [Abstract] [Full Text] [Related]
15. Chronic polyarthritis as isolated manifestation of toxocariasis.
Viola GR; Giacomin MF; França CM; Sallum AM; Jacob CM; Silva CA
Rev Bras Reumatol Engl Ed; 2016; 56(2):185-7. PubMed ID: 27267534
[TBL] [Abstract] [Full Text] [Related]
16. Whole genome sequencing identified new somatic mutations for chronic myelomonocytic leukemia.
Ying Y; Xie JJ; Wang HP; Mao P; Zhou W; Yang Z; Chen XY
Eur Rev Med Pharmacol Sci; 2016; 20(2):278-84. PubMed ID: 26875896
[TBL] [Abstract] [Full Text] [Related]
17. Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia.
Eriksson A; Österroos A; Hassan S; Gullbo J; Rickardson L; Jarvius M; Nygren P; Fryknäs M; Höglund M; Larsson R
Blood Cancer J; 2015 Apr; 5(4):e307. PubMed ID: 25885427
[TBL] [Abstract] [Full Text] [Related]
18. Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer.
Cai P; Guo W; Yuan H; Li Q; Wang W; Sun Y; Li X; Gu Y
Biomed Pharmacother; 2014 Apr; 68(3):285-90. PubMed ID: 24439672
[TBL] [Abstract] [Full Text] [Related]
19. SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies.
Hart S; Goh KC; Novotny-Diermayr V; Hu CY; Hentze H; Tan YC; Madan B; Amalini C; Loh YK; Ong LC; William AD; Lee A; Poulsen A; Jayaraman R; Ong KH; Ethirajulu K; Dymock BW; Wood JW
Leukemia; 2011 Nov; 25(11):1751-9. PubMed ID: 21691275
[TBL] [Abstract] [Full Text] [Related]
20. MTGR1 is required for tumorigenesis in the murine aom/DSS colitis-associated carcinoma model.
Barrett CW; Fingleton B; Williams A; Ning W; Fischer MA; Washington MK; Chaturvedi R; Wilson KT; Hiebert SW; Williams CS
Cancer Res; 2011 Feb; 71(4):1302-12. PubMed ID: 21303973
[TBL] [Abstract] [Full Text] [Related]
[Next]